Association between long-term proton pump inhibitor use and bone mineral density among Jordanian adults: A retrospective study
Journal of Clinical Densitometry · 2026-10 · 29 (4) · 101751
DOI: 10.1016/j.jocd.2026.101751 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Clinical Densitometry, 2026-10. Verfasst von Mu'taz Massad und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, The Hashemite University, P.O. Box 330127, Zarqa, 13133, Jordan. Hauptthemen laut MEDLINE: Bone Density, Famotidine, Osteoporosis, Proton Pump Inhibitors. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Osteoporosis is a common skeletal disease that is defined by low bone density and an increased risk of fracture. It is a widespread health issue with significant health consequences that has recently attracted the attention of the worldwide community. The present research was carried out to test the association between prolonged PPI therapy and bone mineral density among patients in Jordan. METHODS: A retrospective observational study was performed at Al-Zarqa New Governmental and Al-Basheer Hospitals, Jordan. A total of 695 patients aged 20-60 years who underwent dual-energy X-ray absorptiometry (DEXA) were divided into 3 groups: long-term users of PPIs (≥ 12 months), famotidine users (≥ 12 months), and non-users. Bone mineral density (BMD) at the lumbar spine and femoral neck was measured using T- and Z-scores adjusted for age and sex. RESULTS: Of 695 participants, 180 (25.9%) were PPI users, 105 (15.1%) famotidine users, and 410 (59%) non-exposed group. The median age was 53 years, and 90.4% were female. No significant differences were found in femoral neck or lumbar spine BMD and Z-scores between groups. In the T-score group, the lumbar spine T-score differed significantly across groups (p = 0.040), driven by differences between non-exposed group and famotidine users (p = 0.034), with no significant differences involving PPI users. CONCLUSION: Our study provides the literature with unique results in support of the safety of long-term PPI use in terms of BMD. Further research is needed to explore this relationship in more robust study designs that address potential bias and confounding factors and explore it in a healthy population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Faculty of Medicine, The Hashemite University, P.O. Box 330127, Zarqa, 13133, Jordan.
- Faculty of Medicine, The Hashemite University, P.O. Box 330127, Zarqa, 13133, Jordan. Electronic address: 2038303@std.hu.edu.jo.
- Faculty of Medicine, The Hashemite University, P.O. Box 330127, Zarqa, 13133, Jordan.
Zitieren
APA
Massad, M., Alqoudah, M., Saleh, Z. A., Hizzani, Y., Saleh, L., Alsbeehat, L., Ja'afreh, H., Jaber, M., Owiesat, D., Khalaf, L., Sallam, Z., Qutifan, L., Al-Adaileh, Z., Alsharat, A., & Alkousheh, H. (2026). Association between long-term proton pump inhibitor use and bone mineral density among Jordanian adults: A retrospective study. Journal of Clinical Densitometry, 29(4), 101751. https://doi.org/10.1016/j.jocd.2026.101751
Vancouver
Massad M, Alqoudah M, Saleh ZA, Hizzani Y, Saleh L, Alsbeehat L, et al. Association between long-term proton pump inhibitor use and bone mineral density among Jordanian adults: A retrospective study. Journal of Clinical Densitometry. 2026;29(4):101751. doi:10.1016/j.jocd.2026.101751
BibTeX
@article{Massad2026,
author = {Massad, Mu'taz and Alqoudah, Mais and Saleh, Zain Aldeen and Hizzani, Younis and Saleh, Layth and Alsbeehat, Layan and Ja'afreh, Hanin and Jaber, Marah and Owiesat, Dina and Khalaf, Laith and Sallam, Zaid and Qutifan, Lna and Al-Adaileh, Zain and Alsharat, Asma'a and Alkousheh, Hazim},
title = {Association between long-term proton pump inhibitor use and bone mineral density among Jordanian adults: A retrospective study},
journal = {Journal of Clinical Densitometry},
year = {2026},
volume = {29},
number = {4},
pages = {101751},
doi = {10.1016/j.jocd.2026.101751}
}
EUVIMED